ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2026
Cell-Intrinsic Regulation of Epilepsy-Associated Pathology by mTORC1 and mTORC2.
Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dendritic shaft constrictions shape synaptic integration in neurons.Science advances · 2026Article
- Scaling of Neuronal Growth and Excitability Through Separable mTORC1 and mTORC2 Pathways.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Mechanistic target of rapamycin (mTOR) signaling is mediated through mTORC1 and mTORC2. mTORC1 signaling requires the regulatory protein Raptor, while mTORC2 signaling requires Rictor. mTOR signaling is increased during epileptogenesis, and manipulations to inhibit mTOR have been shown to reduce seizure incidence in some epilepsy models. Inhibiting mTOR signaling is hypothesized to prevent epileptogenic changes. To test this hypothesis and to assess how mTORC1 and mTORC2 might modulate epileptogenesis, we deleted Raptor or Rictor from a subset of hippocampal dentate granule cells in male and female mice to cell-autonomously inhibit mTORC1 or mTORC2, respectively. Gene deletion effects were examined in healthy mice and following status epilepticus, which leads to the development of epilepsy. Raptor and Rictor knock-out (KO) cells had fewer dendritic spines than neighboring wild-type cells, and Raptor KO cells had reduced presynaptic terminal volume and contributed less to mossy fiber axon sprouting. Raptor deletion decreased somatic contact with parvalbumin inhibitory neuron puncta and reduced soma area, while Rictor KO cells were more likely to be c-Fos immunoreactive. Findings demonstrate that Raptor and Rictor deletion exert mixed effects on morphological changes associated with epilepsy, implying that mTORC1 and mTORC2 have both overlapping and distinct neuroanatomical targets. In addition, the magnitude of gene deletion effects was similar in saline and SE-exposed animals. The observation implies that rather than specifically blocking epileptogenic circuit rewiring in acquired epilepsy, mTOR inhibition acts similarly on granule cells in healthy and epileptic mice to produce mixed changes on structures underlying excitatory and inhibitory synaptic transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.